GLAXOSMITHKLINE BEGINS TESTING NEW TECHNOLOGY TO PROTECT PATIENTS AGAINST COUNTERFEIT MEDICINE

GlaxoSmithKline has begun distributing a medicine tagged with radio frequency identification (RFID) technology as part of a pilot project to help protect patient safety.
Finanzen.net